Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

Abstract Background The role of axillary lymph node dissection (ALND) has increasingly been called into question among patients with positive sentinel lymph nodes. Two recent trials have failed to show a survival difference in sentinel node-positive breast cancer patients who were randomized either...

Full description

Bibliographic Details
Main Authors: Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt, on behalf of the SENOMAC Trialists’ Group
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Cancer
Subjects:
Breast cancer
Sentinel lymph node biopsy
Axillary lymph node dissection
Survival
Macrometastasis
Online Access:http://link.springer.com/article/10.1186/s12885-017-3361-y

Internet

http://link.springer.com/article/10.1186/s12885-017-3361-y

Similar Items